Tag: Combination

Eisai Co., Ltd. announced today that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inhibitor discovered by Eisai, in combination with Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada)’s KEYTRUDA (generic name: pembrolizumab) has been approved in Taiwan for the treatment of patients with advanced endometrial carcinoma who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation. The approval is based on results from the pivotal Phase 3 Study 309/KEYNOTE-775 trial. These results were presented at the Society of Gynecologic ... Read more

Download Full Size Image”> Park City – UT– www.e-janco.com –Janco has analyzed the potential impact of the proposed tax plans and estimates that 50,000 to 75,000 IT jobs will be lost if the taxes proposed are passed. The CEO of Janco Associates, Inc., Mr. M. Victor Janulaitis said, “The proposed increased corporate tax rates, reinstatement of the minimum tax, elimination of expensing investments, elimination of reduced capital gains tax, and higher individual tax rates will slow if not stop investments in IT. This in turn will slow the expansion of the IT job market. This will start as soon as ... Read more